Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blinded, Placebo-controlled Study to Assess the Efficacy and Safety of Omacor® in Taiwanese Hypertriglyceridemic Patients

NCT01725646 is registered in ClinicalTrials.gov with Excelsior as lead sponsor.

NCT NCT01725646
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01725646 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blinded, Placebo-controlled Study to Assess the Efficacy and Safety of Omacor® in Taiwanese Hypertriglyceridemic Patients
Lead sponsor
Excelsior
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2011
Completion date
August 31, 2013
Enrollment
253 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hypertriglyceridemia